Literature DB >> 24431629

Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population.

Necmiye Dover1, Hacer C Gulerman1, Sevki Celen1, Serkan Kahyaoglu1, Okan Yenicesu1.   

Abstract

OBJECTIVE: Placental growth factor (PlGF) is an angiogenetic factor and inducts the development of preeclampsia in a hypoxic environment. In this study, we examined maternal blood PlGF levels in a pregnant population between 16 and 19 weeks of gestation for determining the prospective value for early diagnosis of preeclampsia as a screening test.
MATERIALS AND METHODS: In this prospective cross-sectional study, 114 nulliparous normotensive pregnant women were selected for the control group and 34 patients who have chronic hypertension or had a medical history of hypertensive disorders in previous pregnancies were selected for the study group.
RESULTS: In the study group, the risk of preeclampsia increased 3.2 times when compared with the control with a confidence interval of 95 %. The cut-off value for PlGF for discriminating preeclamptic and non-preeclamptic patients was found to be 62.5 pg/ml.
CONCLUSION: Patients with a medical history of hypertensive disorders and low PIGF levels in early second trimester have an increased risk for preeclampsia.

Entities:  

Keywords:  Angiogenesis; Placental growth factor; Preeclampsia

Year:  2012        PMID: 24431629      PMCID: PMC3696145          DOI: 10.1007/s13224-012-0279-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  14 in total

Review 1.  Screening for pre-eclampsia--lessons from aneuploidy screening.

Authors:  H S Cuckle
Journal:  Placenta       Date:  2011-02       Impact factor: 3.481

2.  Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) pre-eclampsia.

Authors:  Aly Youssef; Francesca Righetti; Danila Morano; Nicola Rizzo; Antonio Farina
Journal:  Prenat Diagn       Date:  2011-10-28       Impact factor: 3.050

Review 3.  Role of placenta growth factor in cardiovascular health.

Authors:  Shalini Iyer; K Ravi Acharya
Journal:  Trends Cardiovasc Med       Date:  2002-04       Impact factor: 6.677

4.  The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy.

Authors:  P M Kyle; D Buckley; J Kissane; M de Swiet; C W Redman
Journal:  Am J Obstet Gynecol       Date:  1995-09       Impact factor: 8.661

5.  Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

6.  Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia.

Authors:  S C Tidwell; H N Ho; W H Chiu; R J Torry; D S Torry
Journal:  Am J Obstet Gynecol       Date:  2001-05       Impact factor: 8.661

7.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Expression of vascular endothelial growth factor and placenta growth factor in human placenta.

Authors:  P Vuorela; E Hatva; A Lymboussaki; A Kaipainen; V Joukov; M G Persico; K Alitalo; E Halmesmäki
Journal:  Biol Reprod       Date:  1997-02       Impact factor: 4.285

9.  Preeclampsia is associated with reduced serum levels of placenta growth factor.

Authors:  D S Torry; H S Wang; T H Wang; M R Caudle; R J Torry
Journal:  Am J Obstet Gynecol       Date:  1998-12       Impact factor: 8.661

10.  Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia.

Authors:  Augustine Rajakumar; Ana Sofia Cerdeira; Sarosh Rana; Zsuzsanna Zsengeller; Lia Edmunds; Arun Jeyabalan; Carl A Hubel; Isaac E Stillman; Samir M Parikh; S Ananth Karumanchi
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

View more
  1 in total

Review 1.  Placental Tissues as Biomaterials in Regenerative Medicine.

Authors:  Annelise Roy; Morgan Mantay; Courtney Brannan; Sarah Griffiths
Journal:  Biomed Res Int       Date:  2022-04-21       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.